Related references
Note: Only part of the references are listed.Partial dopamine depletion in MPTP-treated mice differentially altered motor skill learning and action control
Laure Chagniel et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Classic and New Animal Models of Parkinson's Disease
Javier Blesa et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Murine Motor and Behavior Functional Evaluations for Acute 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine(MPTP) Intoxication
Jessica A. L. Hutter-Saunders et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer's disease
Lakshman Puli et al.
JOURNAL OF NEUROINFLAMMATION (2012)
High-dose Intravenous Immunoglobulin Treatment Increases Regulatory T Cells in Patients with Eosinophilic Granulomatosis with Polyangiitis
Naomi Tsurikisawa et al.
JOURNAL OF RHEUMATOLOGY (2012)
High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice
M. Bousquet et al.
NEUROBIOLOGY OF DISEASE (2012)
Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo
Barbara Bosier et al.
NEUROPHARMACOLOGY (2012)
Novel role of aquaporin-4 in CD4+CD25+T regulatory cell development and severity of Parkinson's disease
Ying Chi et al.
AGING CELL (2011)
Tyrosine hydroxylase and regulation of dopamine synthesis
S. Colette Daubner et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
Susan Duty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy
S. V. Kaveri et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Intravenous immunoglobulin G (IVIG) inhibits IL-1-and TNF-α-dependent, but not chemotactic-factor-stimulated, neutrophil transendothelial migration
Andrew C. Issekutz et al.
CLINICAL IMMUNOLOGY (2011)
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor
Alessandra Nicoletti et al.
CYTOKINE (2011)
High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice
Charlotte Starke et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer's Disease Model
Masashi Kitazawa et al.
JOURNAL OF IMMUNOLOGY (2011)
Plasma exchange and intravenous immunoglobulins: Mechanism of action in immune-mediated neuropathies
Helmar C. Lehmann et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
Janelle Drouin-Ouellet et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Myeloperoxidase-Specific Plasma Cell Depletion by Bortezomib Protects from Anti-Neutrophil Cytoplasmic Autoantibodies-Induced Glomerulonephritis
Julia Bontscho et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Pathological roles of α-synuclein in neurological disorders (vol 10, pg 1015, 2011)
K. Vekrellis et al.
LANCET NEUROLOGY (2011)
A Tale on Animal Models of Parkinson's Disease
Erwan Bezard et al.
MOVEMENT DISORDERS (2011)
Progesterone receptor isoforms differentially regulate the expression of tryptophan and tyrosine hydroxylase and glutamic acid decarboxylase in the rat hypothalamus
Oscar Gonzalez-Flores et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
MPTP-Induced Neuroinflammation Increases the Expression of Pro-Inflammatory Cytokines and Their Receptors in Mouse Brain
Dario Domenico Lofrumento et al.
NEUROIMMUNOMODULATION (2011)
α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients
Kiran Yanamandra et al.
PLOS ONE (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
Passively Administered Pooled Human Immunoglobulins Exert IL-10 Dependent Anti-Inflammatory Effects that Protect against Fatal HSV Encephalitis
Chandran Ramakrishna et al.
PLOS PATHOGENS (2011)
Modulation of Tyrosine Hydroxylase, Neuropeptide Y, Glutamate, and Substance P in Ganglia and Brain Areas Involved in Cardiovascular Control after Chronic Exposure to Nicotine
Merari F. R. Ferrari et al.
INTERNATIONAL JOURNAL OF HYPERTENSION (2011)
Pathological roles of α-synuclein in neurological disorders
Kostas Vekrellis et al.
LANCET NEUROLOGY (2011)
Control of Th2-Mediated Inflammation by Regulatory T Cells
K. Venuprasad Poojary et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease
Toru Yasuda et al.
APOPTOSIS (2010)
Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation
Eric Aubin et al.
BLOOD (2010)
Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparations
L. M. Patrias et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
In vivo modulation of the expressions of Fas and CD25 by intravenous immunoglobulin in common variable immunodeficiency
Hasibe Artac et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2010)
Intravenous Immunoglobulins as a Treatment for Alzheimer's Disease Rationale and Current Evidence
Richard Dodel et al.
DRUGS (2010)
A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson's disease
Katia Varani et al.
FASEB JOURNAL (2010)
Mechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy
Bjoern Tackenberg et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson's Disease
Ashley D. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2010)
Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
Johanna Magga et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL/lpr mouse model of systemic lupus
Z. Racz et al.
LUPUS (2010)
Missing pieces in the Parkinson's disease puzzle
Jose A. Obeso et al.
NATURE MEDICINE (2010)
Apoptosis of peripheral blood lymphocytes in Parkinson patients
Matil Calopa et al.
NEUROBIOLOGY OF DISEASE (2010)
Involvement of Fc Receptors in Disorders of the Central Nervous System
Eitan Okun et al.
NEUROMOLECULAR MEDICINE (2010)
Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance
Paula Scalzo et al.
NEUROSCIENCE LETTERS (2010)
Improved mouse models for the study of treatment modalities for immune-mediated platelet destruction
Yulia Katsman et al.
TRANSFUSION (2010)
FOXP3+ regulatory T cells in the human immune system
Shimon Sakaguchi et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Safety and Efficacy of PrivigenA (R), a Novel 10% Liquid Immunoglobulin Preparation for Intravenous Use, in Patients with Primary Immunodeficiencies
Mark R. Stein et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and α-synuclein inclusions
Claire Gibrat et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Therapeutic activities of intravenous immunoglobulins in multiple sclerosis involve modulation of chemokine expression
Nadine Pigard et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease
Paula Scalzo et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
Norman R. Relkin et al.
NEUROBIOLOGY OF AGING (2009)
Interleukin-6 Serum Levels in Patients with Parkinson's Disease
Kerly Wollmeister Hofmann et al.
NEUROCHEMICAL RESEARCH (2009)
Anti-inflammatory actions of intravenous immunoglobulin
Falk Nimmerjahn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Role of natural antibodies in immune homeostasis: IVIg perspective
Janakiraman Vani et al.
AUTOIMMUNITY REVIEWS (2008)
Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin:: a critical factor in controlling experimental autoimmune encephalomyelitis
Amal Ephrem et al.
BLOOD (2008)
Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immuno suppressive therapy
Derin B. Keskin et al.
CYTOKINE (2008)
Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease
M. Bousquet et al.
FASEB JOURNAL (2008)
Variation of anti-Fas antibodies in different lots of intravenous immunoglobulin
B. M. Reipert et al.
VOX SANGUINIS (2008)
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease
Ashley D. Reynolds et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system:: Microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb
Anne Vroon et al.
EXPERIMENTAL GERONTOLOGY (2007)
Higher frequency of regulatory T suppressive activity cells in the elderly and increased in neurodegeneration
Daniela Rosenkranz et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Autoantibodies to alpha-synuclein in inherited Parkinson's disease
Katerina K. Papachroni et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Intravenous immunoglobulin:: An update on the clinical use and mechanisms of action
Vir-Singh Negi et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2007)
P53 protein, interferon-γ, and NF-κB levels are elevated in the parkinsonian brain
Makio Mogi et al.
NEUROSCIENCE LETTERS (2007)
Protocol for the MPTP mouse model of Parkinson's disease
Vernice Jackson-Lewis et al.
NATURE PROTOCOLS (2007)
IVIg attenuates T cell-mediated killing of human neurons
Angela D. Janke et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Intravenous immunoglobulin in autoimmune disorders: An insight into the immunoregulatory mechanisms
J Bayry et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
CD4+/CD8+ macrophages infiltrating at inflammatory sites:: a population of monocytes/macrophages with a cytotoxic phenotype
T Baba et al.
BLOOD (2006)
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
P Klivenyi et al.
NEUROBIOLOGY OF DISEASE (2006)
Behavioral models of Parkinson's disease in rodents: A new look at an old problem
Gloria E. Meredith et al.
MOVEMENT DISORDERS (2006)
A call for clinically driven experimental design in assessing neuroprotection in experimental Parkinsonism
Erwan Bezard
BEHAVIOURAL PHARMACOLOGY (2006)
A possible role for humoral immunity in the pathogenesis of Parkinson's disease
CF Orr et al.
BRAIN (2005)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
Absence of inclusion body formation in the MPTP mouse model of Parkinson's disease
M Shimoji et al.
MOLECULAR BRAIN RESEARCH (2005)
Parkinson-like syndrome induced by continuous MPTP infusion:: Convergent roles of the ubiquitin-proteasome system and α-synuclein
F Fornai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mice lacking α-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration
RE Drolet et al.
NEUROTOXICOLOGY (2004)
IVIg therapy in brain inflammation: etiology-dependent differential effects on leucocyte recruitment
BM Lapointe et al.
BRAIN (2004)
Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of γ-synuclein, α-synuclein and double α/γ-synuclein null mutant mice
DC Robertson et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Toxic epidermal necrolysis treated with low-dose intravenous immunoglobulin: immunohistoichemical study of Fas and Fas-Ligand expression
K Ito et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2004)
Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway
MW Jakowec et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency - A randomized double-blind trial
CM Roifman et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Clinical pharmacology and neuroprotection in Parkinson's disease
M Nomoto
PARKINSONISM & RELATED DISORDERS (2003)
Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine-induced parkinsonism in mice
OM Schluter et al.
NEUROSCIENCE (2003)
Properties of a new intravenous immunoglobulin (IGIV-C, 10%) produced by virus inactivation with caprylate and column chromatography
W Lebing et al.
VOX SANGUINIS (2003)
The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's disease
P Jenner
PARKINSONISM & RELATED DISORDERS (2003)
Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex (TM), 10%)
M Ballow et al.
VOX SANGUINIS (2003)
Behavioral changes are not directly related to striatal monoamme levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice
E Rousselet et al.
NEUROBIOLOGY OF DISEASE (2003)
Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice
J Tan et al.
NATURE NEUROSCIENCE (2002)
Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
W Dauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Role of Fcγ receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra
Y He et al.
EXPERIMENTAL NEUROLOGY (2002)
Increase in peripheral CD4 bright+ CD8 dull+ T cells in Parkinson disease
K Hisanaga et al.
ARCHIVES OF NEUROLOGY (2001)
Effect of MPTP-induced denervation on basal ganglia GABAB receptors:: Correlation with dopamine concentrations and dopamine transporter
F Calon et al.
SYNAPSE (2001)
Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism
J Bas et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors
M Stangel et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
α-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the Parkinsonian toxin MPTP
M Vila et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
